Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe Safety of Sumatriptan and Naratriptan in Pregnancy: What Have We Learned?
Headache: The Journal of Head and Face Pain, 10/07/09
Cunnington M et al. – The risk of all major birth defects following first–trimester exposure to sumatriptan was 4.6% (95% CI 2.9–7.2%). This coupled with a consistent failure of additional epidemiological studies to observe a signal for major teratogenicity gives a level of reassurance concerning the safety of sumatriptan in pregnancy. There are too few data on naratriptan to draw definitive conclusions, and the sample size for sumatriptan remains too small to detect any but very large increases in specific birth defects.
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
The management of paracetamol poisoning
Paediatrics and Child Health, 11/09/09
A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding
Clinical Therapeutics, 11/02/09
Use of Fertility Drugs and Risk of Uterine Cancer: Results From a Large Danish Population-based Cohort Study
American Journal of Epidemiology, 11/04/09
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Use of oral ketamine in chronic pain management: A review
European Journal of Pain, 11/02/09
Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial
Diabetic Medicine, 10/01/09
Acute back pain: benefits and risks of current treatments
Current Medical Research and Opinion, 11/19/09
Sponsor
Article Search
Sponsor